Severe sepsis in two Ugandan hospitals: A prospective observational study of management and outcomes in a predominantly HIV-1 infected population

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Jacob, Shevin T ^a   Moore, Christopher C ^b   Banura, Patrick ^c   Pinkerton, Relana ^b   Meya, David ^d   Opendi, Pius ^e   Reynolds, Steven J ^e,f,g   Kenya Mugisha, Nathan ^h   Mayanja Kizza, Harriet ^d   Scheld, W Michael ^b   Kalisa, Cassim ⁱ   Kimuli, Kasozi ⁱ   Nganizi, Angelo ⁱ   Omongot, Samson ⁱ   Burke, Rebecca ⁱ   Horton, Cheryl Lynn ⁱ   Ssali, Francis ^c   Sekayiba, Scholastica ^c   Ddikusoka, Patrick ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c Masaka Regional Referral Hospital   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

^e RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MINISTRY OF HEALTH   (Uganda)

ⁱ Mulago Accident and Emergency Department   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; METRONIDAZOLE; OXACILLIN; PENICILLIN G;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; ESCHERICHIA COLI; FEMALE; FLUID RESUSCITATION; GLASGOW COMA SCALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KARNOFSKY PERFORMANCE STATUS; LABORATORY TEST; LEUKOCYTOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTION; SALMONELLA; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TACHYPNEA; THROMBOCYTOPENIA; TREATMENT OUTCOME; UGANDA; VITAL SIGN; AIDS RELATED COMPLEX; CYTOLOGY; HOSPITALIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PROSPECTIVE STUDY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME; UGANDA;

EID: 70450187126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007782     Document Type: Article

References (47)

1. Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, et al. (2002) Reducing mortality in sepsis: new directions. Crit Care 6 Suppl 3: S1-18.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
3. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
4. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150.
5. Archibald LK, den Dulk MO, Pallangyo KJ, Reller LB (1998) Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized adults in Dar es Salaam, Tanzania. Clin Infect Dis 26: 290-6.
6. Archibald LK, Reller LB (2001) Clinical microbiology in developing countries. Emerg Infect Dis 7: 302-5.
7. Archibald LK, McDonald LC, Nwanyanwu O, Kazembe P, Dobbie H, et al. (2000) A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis 181: 1414-20.
8. Arthur G, Nduba VN, Kariuki SM, Kimari J, Bhatt SM, et al. (2001) Trends in bloodstream infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. Clin Infect Dis 33: 248-56.
9. Peters RP, Zijlstra EE, Schijffelen MJ, Walsh AL, Joaki G, et al. (2004) A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Trop Med Int Health 9: 928-34.
10. Gilks CF, Brindle RJ, Otieno LS, Simani PM, Newnham RS, et al. (1990) Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 336: 545-9.
11. Grant AD, Djomand G, De Cock KM (1997) Natural history and spectrum of disease in adults with HIV/AIDS in Africa. Aids 11 Suppl B: 43-54.
12. Gordon MA, Walsh AL, Chaponda M, Soko D, Mbvwinji M, et al. (2001) Bacteraemia and mortality among adult medical admissions in Malawi-predominance of non-typhi salmonellae and Streptococcus pneumoniae. J Infect 42: 44-9.
13. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-77.
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine 36: 296-327.
15. Becker JU, Theodosis C, Jacob ST, Wira CR, Groce NE (2009) Surviving sepsis in low-income and middle-income countries: new directions for care and research. Lancet Infect Dis 9: 577-582.
16. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA (2006) Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 42: 377-82.
17. Dunser MW, Baelani I, Ganbold L (2006) A review and analysis of intensive care medicine in the least developed countries. Crit Care Med 34: 1234-42.
18. Theodosis C, Brenner S (2006) Framework and Rationale for Studying Sepsis in High HIV Seroprevalence Resource Poor Settings: the Livingstone General Hospital Experience. International AIDS Conference Toronto.
19. Blomberg B, Manji KP, Urassa WK, Tamim BS, Mwakagile DS, et al. (2007) Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study. BMC Infect Dis 7: 43.
20. Cheng AC, West TE, Limmathurotsakul D, Peacock SJ (2008) Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Medicine 5: e175.
21. Rivers EP, McIntyre L, Morro DC, Rivers KK (2005) Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 173: 1054-65.
22. Wanyenze R, Kamya M, Liechty CA, Ronald A, Guzman DJ, et al. (2006) HIV counseling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav 10: 361-7.
23. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-55.
24. Mor V, Laliberte L, Morris JN, Wiemann M (1984) The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 53: 2002-7.
25. Karnofsky DA (1961) Meaningful clinical classification of therapeutic responses to anticancer drugs. Clin Pharmacol Ther 2: 709-712.
26. Erikstrup C, Kallestrup P, Zinyama R, Gomo E, Mudenge B, et al. (2007) Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa. J Acquir Immune Defic Syndr 44: 478-483.
27. Moore CC, Jacob ST, Pinkerton R, Banura P, Meya DB, et al. (2009) Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malaria. Am J Trop Med Hyg 80: 723-728.
28. Moore CC, Jacob ST, Pinkerton R, Meya DB, Mayanja-Kizza H, et al. (2008) Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda. Clinical Infectious Diseases 46: 215-222.
29. Health Management Information (HMIS) Database Mulago Hospital Complex (2008).
30. Health Management Information (HMIS) Database Masaka Regional Referral Hospital Complex (2008).
31. Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, et al. (2003) Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168: 77-84.
32. Sharma B, Sharma M, Majumder M, Steier W, Sangal A, et al. (2007) Thrombocytopenia in septic shock patients-a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care 35: 874-880.
33. Martin CM, Priestap F, Fisher H, Fowler RA, Heyland DK, et al. (2009) A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med 37: 81-88.
34. Carcillo JA, Davis AL, Zaritsky A (1991) Role of early fluid resuscitation in pediatric septic shock. JAMA 266: 1242-5.
35. Bochud PY, Glauser MP, Calandra T (2001) Antibiotics in sepsis. Intensive Care Med 27 Suppl 1: 33-48.
36. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, et al. (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244: 379-86.
37. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, et al. (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34: 1589-1596.
38. WHO (2007) Clinical Management of HIV and AIDS at District Level. World Wide Web http://www.searo.who.int/LinkFiles/Publications_ch9.pdf.
39. (2004) Integrated Management of Adult and Adolescent Illness: Interim Guidelines for First-Level Facility Health Workers at Health Centre and District Outpatient Clinic.
40. Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, et al. (2008) Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 46: 963-969.
41. Ssali FN, Kamya MR, Wabwire-Mangen F, Kasasa S, Joloba M, et al. (1998) A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol 19: 484-489.
42. McDonald LC, Archibald LK, Rheanpumikankit S, Tansuphaswadikul S, Eampokalap B, et al. (1999) Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet 354: 1159-63.
43. Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283-1297.
44. Ogwal-Okeng JW, Obua C, Waako P, Aupont O, Ross-Degnan D (2004) A comparison of prescribing practices between public and private sector physicians in Uganda. East Afr Med J Suppl: S12-S16.
45. Awad AI, Eltayeb IB (2007) Self-medication practices with antibiotics and antimalarials among Sudanese undergraduate university students. Ann Pharmacother 41: 1249-1255.
46. Anyama N, Adome RO (2003) Community pharmaceutical care: an 8-month critical review of two pharmacies in Kampala. Afr Health Sci 3: 87-93.
47. 2008 Report on the global AIDS epidemic (2008) Status of the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008.